MAX
График AdvisorShares Psychedelics ETF
Простой график
Расширенный график
Основные параметры
| 10 летняя доходность | 0 |
| 3 летняя доходность | 32.79 |
| 5 летняя доходность | 0 |
| ISIN | US00768Y3624 |
| Бета | 0.14 |
| Валюта | usd |
| Владелец | AdvisorShares |
| Годовая доходность | 6.6 |
| Дата основания | 2021-09-15 |
| Див доходность | 0.31 |
| Индекс | ACTIVE - No Index |
| Количество компаний | 13 |
| Комиссия | 0.99 |
| Регион | Global |
| Сайт | cсылка |
| Средний P/BV | 1.75 |
| Средний P/E | 9.37 |
| Средний P/S | 2.15 |
| Страна | USA |
| Страна ISO | US |
| Тип актива | Equity |
| Топ 10 эмитентов, % | 57.12 |
| Изменение за день | 0% 16.27 $ |
| Изменение за неделю | -6.33% 17.37 $ |
| Изменение за месяц | +2.13% 15.93 $ |
| Изменение за 3 месяца | -5.41% 17.2 $ |
| Изменение за полгода | -18.38% 19.93 $ |
| Изменение за год | +6.62% 15.26 $ |
| Изменение с начала года | -5.65% 17.25 $ |
Оплатите подписку
Больше функциональности и данных для анализа компаний и портфеля доступно по подписке
Топ компаний
| Название | Отрасль | Доля, % | P/BV | P/S | P/E | EV/Ebitda | Дивидендная доходность | |
| #1 |
 COMPASS Pathways plc |
Healthcare | 7.8644 | 1.65 | 0 | -1.91 | -0.69 | 0 |
| #2 |
 Alkermes plc |
Healthcare | 7.7698 | 3.32 | 3.13 | 13.27 | 9.4 | 0 |
| #3 |
 Relmada Therapeutics, Inc. |
Healthcare | 6.6722 | 0.39 | 0 | -0.21 | -0.12 | 0 |
| #4 |
 GH Research PLC |
Healthcare | 6.1726 | 2.04 | 0 | -17.08 | -6.96 | 0 |
| #5 |
 Neurocrine Biosciences |
Healthcare | 5.8272 | 5.49 | 6.03 | 41.64 | 22.57 | 0 |
| #6 |
 Supernus Pharmaceuticals, Inc. |
Healthcare | 5.2346 | 0.0027 | 3.92 | -73.08 | 1941.46 | 0 |
| #7 |
 Alto Neuroscience, Inc. |
Healthcare | 5.0798 | 1.93 | 0 | -1.26 | -2.06 | 0 |
| #8 |
 AbbVie |
Healthcare | 4.6133 | 92.87 | 6.6 | 95.5 | 25.13 | 2.98 |
| #9 |
 Johnson & Johnson |
Healthcare | 4.3527 | 7.21 | 6.24 | 21.94 | 13.34 | 2.79 |
| #10 |
 NRx Pharmaceuticals, Inc. |
Healthcare | 3.5295 | -0.69 | 0 | -1.21 | -1.15 | 0 |
Похожие ETF
Другие ETF от Управляющей компании
| Название | Класс | Категория | Комиссия | Годовая доходность |
| Equity | 0.83 | 88.68 | ||
| Equity | 0.84 | 1.03 | ||
| Equity | 1.18 | 7 | ||
| Equity | 0.95 | -5.36 | ||
| Equity | 1.28 | 8.64 | ||
| Multi-Asset | 1.71 | 10.5 | ||
| Equity | 1.03 | 65.75 | ||
| Equity | 0.9 | 13.53 | ||
| Equity | 1.1 | 12.22 | ||
| Multi-Asset | 1.51 | 18.37 | ||
| Equity | 0.75 | 9.46 | ||
| Equity | 2.84 | -17.46 | ||
| Equity | 1 | 7.16 | ||
| Equity | 1.01 | -9.01 | ||
| Equity | 0.99 | -2.96 |
Описание AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
На основе источников: porti.ru
